[ET Net News Agency, 6 August 2021] WUXI BIO (02269) fell 3% to HK$125.9, dipping below
the 50-D SMA of HK$128.972.
It hits an intra-day low of HK$125.8, and an intra-day high of HK$132. The total shares
traded was 3.03 million, with a value of HK$387.42m. The active buy/sell ratio is 44:56,
with net selling turnover of HK$44.02m. CHINA INNOVATION MARKET SER accounts for greatest
net responsive buying turnover of HK$11.9m, with volume weighted average price of
HK$127.915. UBS SEC accounts for greatest net responsive selling turnover of HK$30.38m,
with volume weighted average price of HK$127.781. The stock has fallen a combined 4.11%
over the past 2 consecutive trading days.
The Hang Seng Index now fell 114 points, or 0.44% to 26,090; the Hang Seng China
Enterprises Index now fell 57 points, or 0.62% to 9,238; the Hang Seng TECH Index now fell
19 points, or 0.29% to 6,695; with an overall turnover of HK$60.26b.
The SSE Composite Index now fell 15 points, or 0.45% to 3,451, with an overall turnover
of RMB253.38b.
The SZSE Component Index now fell 19 points, or 0.13% to 14,852, with an overall
turnover of RMB186.84b.
Basic Information
-------------------------------------------
Nominal 125.900 % Chg -3.00%
High 132.000 Low 125.800
Shares Tr 3.03m Turnover 387.42m
10-D SMA 122.140 %H.V 77.875
20-D SMA 128.925 VWAP 127.810
50-D SMA 128.972 RSI14 48.461
-------------------------------------------
Status: Dipping below the 50-D SMA, active buy/sell ratio is 44:56, with net selling
turnover of HK$44.02m, falling a combined 4.11% over the past 2 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
WUXI BIO (02269) 125.90 -3.00
HUTCHMED (00013) 68.50 +4.58
GENSCRIPT BIO (01548) 38.95 +1.43
INNOVENT BIO (01801) 75.00 -3.85
JXR (01951) 14.10 +0.14
BRII-B (02137) 28.50 +15.38
CANSINOBIO-B (06185) 377.60 -0.89
AKESO-B (09926) 47.30 -0.42
KINTOR PHARMA-B (09939) 74.85 -4.04
ALPHAMAB-B (09966) 21.15 -3.20
-------------------------------------------------
(ed)